After deliberating for fewer than six hours, a New Jersey jury returned a 7-to-1 verdict in favor of Novartis Pharmaceuticals Corporation in a thirteen-day trial involving Zometa, a bisphosphonate drug...
After deliberating for fewer than forty-five minutes, a federal jury in Tampa, Florida returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation in a 3-week trial involving Aredia and...
In two opinions issued by the U.S. District Court for the District of Columbia, the Court dismissed claims brought by 3,200 individual Ecuadorian plaintiffs against DynCorp International for alleged crop,...
Judge Henry L. Adams granted the motion of Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey punitive damages law in a pharmaceutical products liability lawsuit filed in the Middle District...
Chief Judge Mary Lisi of the U.S. District Court for the District of Rhode Island adopted Magistrate Judge Lincoln Almond’s recommendation and entered judgment in favor of Novartis in Patterson...
Judge Roger Titus of the U.S. District Court for the District of Maryland granted summary judgment in favor of Novartis Pharmaceuticals Corporation in a case alleging that plaintiff’s treatment with...
The U.S. District Court for the Eastern District of Washington granted Novartis Pharmaceuticals Corporation’s Daubert motion and so excluded plaintiff’s expert witnesses and then granted summary judgment in favor of...
After two and a half days of trial, the plaintiff in Brown v. Novartis Pharm. Corp., No. 7:08-CV-00130-FL (E.D.N.C.), agreed to dismiss with prejudice his claims against Firm client Novartis...
The U.S. District Court for the Eastern District of Texas granted Novartis Pharmaceuticals Corporation’s motion to strike the purported alternative design declaration of MDL-wide expert Dr. Robert Marx, and then...
Extending a string of cases in which punitive damages claims have been dismissed in the Aredia/Zometa litigation, Novartis Pharmaceuticals Corporation secured dismissal of a plaintiff’s punitive damages claim in the...
The Second Circuit affirmed a defense verdict in Hogan v. Novartis Pharm. Corp., 1:06-260-BMC (E.D.N.Y.). On appeal, plaintiff/appellant argued that the district court erred in denying her last-minute request to...
Judge Tim Leonard of the U.S. District Court for the Western District of Oklahoma granted summary judgment in favor of Novartis Pharmaceuticals Corporation in a case alleging that plaintiff’s treatment...
The U.S. District Court for the Eastern District of Missouri granted Novartis Pharmaceuticals Corporation’s Daubert motion regarding plaintiff’s expert witnesses and then granted summary judgment in favor of Novartis in...
The New Jersey Appellate Division affirmed judgment in favor of Novartis Pharmaceuticals Corporation, rejecting plaintiffs’ appeal of a 2010 defense verdict in the first bellwether trial arising out of the...
Judge Graham Mullen ruled on Novartis’s Daubert motion in a Zometa case, excluding large portions of the opinions of Dr. Suzanne Parisian. Lemons v. Novartis Pharm. Corp., No. 3:08-cv-00361 (W.D.N.C....
